维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="Wenandy"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Cyclosporins: structure-activity relationships for the inhibition of the human FPR1 formylpeptide receptor 显示文摘	Loor F Tiberghien F Wenandy T	2002	Med Chem2002，45，：	1
2	RhoC a new target for therapeutic vaccination against metastatic cancer 显示文摘	Wenandy L Sφrensen RB Svane IM	2008	Cancer Immunol Immunother2008，27，8：	1
3	Cyclosporins:structure-activity relationships for the inhibition of the human MDR1 pglycoprotein ABC transporter显示文摘	Loor F Tiberghien F Wenandy T	2002	J Med Chem2002，45，21：	1
4	Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4~ T cells by the microRNA miR-125b 显示文摘	Rossi RL Rossetti G Wenandy L	2011	Nat Immuuol2011，12，8：	1
5	Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b 显示文摘	Rossi RL Rossetti G Wenandy L	2011	Nat Immunol2011，12，8：	1
6	Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4 + T cells by the microRNA miR-125b 显示文摘	Rossi RL Rossetti G Wenandy L	2011	Nat Immunol2011，12，8：	1
7	Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer显示文摘	Junker N Andersen MH Wenandy L	2011	Cytotherapy2011，13，7：	1
8	The immunogenicity of the hTERT540 -548 peptide in cancer显示文摘	Wenandy L Sorensen RB Sengelov L	2008	Clin Cancer Res2008，14，1：	1
9	The immunogenicity of the hTERT540-548 peptide in cancer显示文摘	Wenandy L Sφrensen RB Sengelφv L	2008	Clin Cancer Res2008，14，1：	1
10	Therapeuticdendritic cell vaccination of patients with metastatic renal cellcarcinoma:a clinical phase 1/2trial显示文摘	Berntsen A Trepiakas R Wenandy L	2008	J Immunother2008，31，8：	1
11	Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+T cells by the microRNA miR-125b显示文摘	Rossi RL Rossetti G Wenandy L Curti S Ripamonti A Bonnal RJ		0，，：	1
12	Ther apeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial显示文摘	Berntsen A Trepiakas R Wenandy L	2008	J Immunother2008，31，8：	1
13	Therapeutic dendrit- ic cell vaccination of patients with metastatic renal cell carcinoma : A clinical phase I / ]1 trial 显示文摘	Berntsen A Trepiakas R Wenandy L	2008	J Imrnunotber2008，31，8：	1
14	Cyclosporins:structureactivity relationships for the inhibition of the human FPR1 formylpeptide receptor显示文摘	Loor F Tiberghien F Wenandy T	2002	J Med Chem2002，45，：	1
15	Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial 显示文摘	Bemtsen A Trepiakas R Wenandy L	2008	J Immunother2008，31，8：	1
16	The im-munogenicity of the hTERT540-548 peptide in cancer显示文摘	Wenandy Lynn S rensen Rikke Baek Sengel v Lisa		0，，01：	1
17	Cyclosporins:structureactivity relationships for the inhibition of the human MDR1 PGlycoprotein ABC transporter显示文摘	Loor F Tiberghien F Wenandy T	2002	J Med Chem2002，45，：	1
18	Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma:a clinical phase 1/2 trial显示文摘	BERNTSEN A TREPIAKAS R WENANDY L	2008	J Immunother2008，31，8：	1
19	The immunogenicity of the hTERT540-548 peptide in cancer 显示文摘	Wenandy L So rensen RB Sengelov L	2008	Clin Cancer Res2008，14，1：	1
20	The immunogenicity of the hTERT540-548 peptide in cancer 显示文摘	Wenandy L Sorensen RB Sengelov L	2008	Clin Cancer Res2008，14，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示